Whole-exome sequencing for genetic diagnosis of idiopathic liver injury in children
- PMID: 38864694
- PMCID: PMC11167704
- DOI: 10.1111/jcmm.18485
Whole-exome sequencing for genetic diagnosis of idiopathic liver injury in children
Abstract
Genome-wide approaches, such as whole-exome sequencing (WES), are widely used to decipher the genetic mechanisms underlying inter-individual variability in disease susceptibility. We aimed to dissect inborn monogenic determinants of idiopathic liver injury in otherwise healthy children. We thus performed WES for 20 patients presented with paediatric-onset recurrent elevated transaminases (rELT) or acute liver failure (ALF) of unknown aetiology. A stringent variant screening was undertaken on a manually-curated panel of 380 genes predisposing to inherited human diseases with hepatobiliary involvement in the OMIM database. We identified rare nonsynonymous variants in nine genes in six patients (five rELT and one ALF). We next performed a case-level evaluation to assess the causal concordance between the gene mutated and clinical symptoms of the affected patient. A genetic diagnosis was confirmed in four rELT patients (40%), among whom two carried novel mutations in ACOX2 or PYGL, and two had previously-reported morbid variants in ABCB4 or PHKA2. We also detected rare variants with uncertain clinical significance in CDAN1, JAG1, PCK2, SLC27A5 or VPS33B in rELT or ALF patients. In conclusion, implementation of WES improves diagnostic yield and enables precision management in paediatric cases of liver injury with unknown aetiology, in particular recurrent hypertransaminasemia.
Keywords: acute liver failure; children; idiopathic hepatic injury; recurrent elevated transaminases; whole‐exome sequencing.
© 2024 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Whole Exome Sequencing Among 26 Patients With Indeterminate Acute Liver Failure: A Pilot Study.Clin Transl Gastroenterol. 2019 Oct;10(10):e00087. doi: 10.14309/ctg.0000000000000087. Clin Transl Gastroenterol. 2019. PMID: 31609742 Free PMC article.
-
Genetic evaluation in indeterminate acute liver failure: A post hoc analysis.Arab J Gastroenterol. 2024 May;25(2):125-128. doi: 10.1016/j.ajg.2024.03.004. Epub 2024 May 4. Arab J Gastroenterol. 2024. PMID: 38705812
-
Recurrent elevated liver transaminases and acute liver failure in two siblings with novel bi-allelic mutations of NBAS.Eur J Med Genet. 2017 Aug;60(8):426-432. doi: 10.1016/j.ejmg.2017.05.005. Epub 2017 May 30. Eur J Med Genet. 2017. PMID: 28576691
-
Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.Front Immunol. 2022 Jun 30;13:906328. doi: 10.3389/fimmu.2022.906328. eCollection 2022. Front Immunol. 2022. PMID: 35874679 Free PMC article. Review.
-
Mutations in NBAS and SCYL1, genetic causes of recurrent liver failure in children: Three case reports and a literature review.Arch Pediatr. 2020 Apr;27(3):155-159. doi: 10.1016/j.arcped.2020.01.003. Epub 2020 Mar 4. Arch Pediatr. 2020. PMID: 32146038 Review.
Cited by
-
Understanding Glycogen Storage Disease Type IX: A Systematic Review with Clinical Focus-Why It Is Not Benign and Requires Vigilance.Genes (Basel). 2025 May 15;16(5):584. doi: 10.3390/genes16050584. Genes (Basel). 2025. PMID: 40428406 Free PMC article. Review.
-
Novel ABCB4 mutation in a female patient with progressive familial intrahepatic cholestasis type 3: a case report and literature review.Ann Med Surg (Lond). 2024 Dec 19;87(2):953-963. doi: 10.1097/MS9.0000000000002813. eCollection 2025 Feb. Ann Med Surg (Lond). 2024. PMID: 40110281 Free PMC article.
References
-
- Della Corte C, Mosca A, Vania A, Alterio A, Alisi A, Nobili V. Pediatric liver diseases: current challenges and future perspectives. Expert Rev Gastroenterol Hepatol. 2016;10(2):255‐265. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous